Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
Clinical Benefits of Leukodepleted Blood Products - 15 Angebote vergleichen
Bester Preis: Fr. 61.36 (€ 62.88)¹ (vom 04.02.2018)Clinical Benefits of Leukodepleted Blood Products (Medical Intelligence Unit) (1995)
ISBN: 9783540588931 bzw. 3540588930, in Deutsch, Springer, Berlin/Heidelberg, Deutschland, Erstausgabe.
Von Händler/Antiquariat, Better World Books [51315977], Mishawaka, IN, U.S.A.
Shows some signs of wear, and may have some markings on the inside. 100% Money Back Guarantee. Shipped to over one million happy customers. Your purchase benefits world literacy!
Clinical Benefits of Leukodepleted Blood Products (Medical Intelligence Unit) (1995)
ISBN: 9781570591228 bzw. 1570591229, in Englisch, 198 Seiten, Springer, Taschenbuch, neu.
Von Händler/Antiquariat, affordable2015.
Joseph Sweeney, Andrew Heaton he presence of allogeneic leukocytes in blood products received little T attention until the mid-1950s when these "passenger" cells were im plicated in the etiology of febrile transfusion reactions, and early strate gies based on centrifugation were developed to effect their removal. In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion. White cells are the least numerous of the cellular elements in blood and ratios of white cells to platelets and white cells to red cells are ap proximately 1:15 to 1:1000 respectively. This ratio is maintained in whole blood, but may be altered slightly in the process of component prepara tion. Any production or processing step which intentionally decreases this ratio will result in a product which can be described as white cell depleted. It has, however, become more common to define the outcome as a residual white cell content, rather than a decrease in cellular ratios, although the latter makes more sense on theoretical grounds, since deple tion of white cells needs to be put in the context of any unintentional loss of red cells or platelets. The end result of this intentional processing step, therefore, is generally expressed as the residual absolute number of white cells or as the degree of difference in white cell content, the latter expressed as either a percentage change or as a logarithmic reduction. Paperback, Ausgabe: Softcover reprint of the original 1st ed. 1995, Label: Springer, Springer, Produktgruppe: Book, Publiziert: 1995-01-01, Studio: Springer, Verkaufsrang: 12379822.
Clinical Benefits of Leukodepleted Blood Products (Medical Intelligence Unit) (1995)
ISBN: 9781570591228 bzw. 1570591229, in Englisch, 198 Seiten, Springer, Taschenbuch, gebraucht.
Von Händler/Antiquariat, Roadkill Books.
Joseph Sweeney, Andrew Heaton he presence of allogeneic leukocytes in blood products received little T attention until the mid-1950s when these "passenger" cells were im plicated in the etiology of febrile transfusion reactions, and early strate gies based on centrifugation were developed to effect their removal. In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion. White cells are the least numerous of the cellular elements in blood and ratios of white cells to platelets and white cells to red cells are ap proximately 1:15 to 1:1000 respectively. This ratio is maintained in whole blood, but may be altered slightly in the process of component prepara tion. Any production or processing step which intentionally decreases this ratio will result in a product which can be described as white cell depleted. It has, however, become more common to define the outcome as a residual white cell content, rather than a decrease in cellular ratios, although the latter makes more sense on theoretical grounds, since deple tion of white cells needs to be put in the context of any unintentional loss of red cells or platelets. The end result of this intentional processing step, therefore, is generally expressed as the residual absolute number of white cells or as the degree of difference in white cell content, the latter expressed as either a percentage change or as a logarithmic reduction. Paperback, Ausgabe: Softcover reprint of the original 1st ed. 1995, Label: Springer, Springer, Produktgruppe: Book, Publiziert: 1995-01-01, Studio: Springer, Verkaufsrang: 12379822.
Clinical Benefits of Leukodepleted Blood Products
ISBN: 9783662265383 bzw. 3662265389, in Englisch, Springer Berlin Heidelberg, neu, E-Book, elektronischer Download.
Joseph Sweeney, Andrew Heaton he presence of allogeneic leukocytes in blood products received little T attention until the mid-1950s when these "passenger" cells were im- plicated in the etiology of febrile transfusion reactions, and early strate- gies based on centrifugation were developed to effect their removal.In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion.White cells are the least numerous of the cellular elements in blood and ratios of white cells to platelets and white cells to red cells are ap- proximately 1:15 to 1:1000 respectively.This ratio is maintained in whole blood, but may be altered slightly in the process of component prepara- tion.Any production or processing step which intentionally decreases this ratio will result in a product which can be described as white cell depleted.It has, however, become more common to define the outcome as a residual white cell content, rather than a decrease in cellular ratios, although the latter makes more sense on theoretical grounds, since deple- tion of white cells needs to be put in the context of any unintentional loss of red cells or platelets.The end result of this intentional processing step, therefore, is generally expressed as the residual absolute number of white cells or as the degree of difference in white cell content, the latter expressed as either a percentage change or as a logarithmic reduction.
Clinical Benefits of Leukodepleted Blood Products (1994)
ISBN: 9781570591228 bzw. 1570591229, in Englisch, Springer, Taschenbuch, neu.
bol.com.
Provides a state-of-the-art description of the current status of leukodepleted blood products. Advances in technology, particularly filtration, have achieved great success in the selective removal of these white cells, and this book examines the benefits of such blood products. Productinformatie:Taal: Engels;Afmetingen: 0x0x0 mm;Gewicht: 0,00 gram;ISBN10: 1570591229;ISBN13: 9781570591228; Engels | Paperback | 1994.
Clinical Benefits of Leukodepleted Blood Products
ISBN: 9781570591228 bzw. 1570591229, in Englisch, neu.
Clinical Benefits of Leukodepleted Blood Products, Joseph Sweeney, Andrew Heaton he presence of allogeneic leukocytes in blood products received little T attention until the mid-1950s when these "passenger" cells were im plicated in the etiology of febrile transfusion reactions, and early strate gies based on centrifugation were developed to effect their removal. In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion. White cells are the least numerous of the cellular elements in blood and ratios of white cells to platelets and white cells to red cells are ap proximately 1:15 to 1:1000 respectively. This ratio is maintained in whole blood, but may be altered slightly in the process of component prepara tion. Any production or processing step which intentionally decreases this ratio will result in a product which can be described as white cell depleted. It has, however, become more common to define the outcome as a residual white cell content, rather than a decrease in cellular ratios, although the latter makes more sense on theoretical grounds, since deple tion of white cells needs to be put in the context of any unintentional loss of red cells or platelets. The end result of this intentional processing step, therefore, is generally expressed as the residual absolute number of white cells or as the degree of difference in white cell content, the latter expressed as either a percentage change or as a logarithmic reduction.
Clinical Benefits of Leukodepleted Blood Products (Medical Intelligence Unit) (1995)
ISBN: 9783540588931 bzw. 3540588930, in Deutsch, Springer, gebraucht, Erstausgabe.
Von Händler/Antiquariat, Better World Books [51315977], Mishawaka, IN, U.S.A.
Shows some signs of wear, and may have some markings on the inside.
Clinical Benefits of Leukodepleted Blood Products (1995)
ISBN: 9783540588931 bzw. 3540588930, in Englisch, 208 Seiten, Springer-Verlag Berlin and Heidelberg GmbH & Co. K, gebraucht.
Von Händler/Antiquariat, FastMedia "navi da Stati USA"
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Clinical Benefits of Leukodepleted Blood Products (Medical Intelligence Unit) (1995)
ISBN: 9783540588931 bzw. 3540588930, in Englisch, 208 Seiten, Springer-Verlag Berlin and Heidelberg GmbH & Co. K, gebraucht.
Von Händler/Antiquariat, FastMedia "Despachos de USA"
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Clinical Benefits of Leukodepleted Blood Products (Medical Intelligence Unit) (1995)
ISBN: 9783540588931 bzw. 3540588930, in Deutsch, Springer, gebraucht, Erstausgabe.
Von Händler/Antiquariat, Better World Books [51315977], Mishawaka, IN, U.S.A.
Great condition for a used book! Minimal wear.